No Repro Fee.
Irish biotech startup, Inform Bioscience, has signed a license agreement with the world renowned Mayo Clinic, USA to acquire a portfolio of biomarkers for use in developing a prognostic test to detect preeclampsia in pregnancy. Pictured at the Biomedical Diagnostics Institute (BDI) at DCU are from (left to right): Dr. Keith O’Neill, Enterprise Ireland, Dr. Christine Loscher, BDI, Charles Garvey, Inform Bioscience and Dr. Vesna Garovic, Mayo Clinic. Pic. Robbie Reynolds